Borras-FernandezI, Montes-ChineaN, CastilloB, CruzM: American Academy of Physical Medicine and Rehabilitation. Functional Assessment. https://now.aapmr.org/functional-assessment. May 2, 2016. Updated May 2, 2016. (Last accessed November11, 2020).
2.
BiermanAS: Functional status: The six vital sign. J Gen Intern Med, 2001; 16:785–786.
3.
KatzS, DownsTD, CashHR, GrotzRC: Progress in development of the index of ADL. Gerontologist, 1970; 10:20–30.
José A, Dal Corso S: Reproducibility of the six-minute walk test and Glittre ADL-test in patients hospitalized for acute and exacerbated chronic lung disease. Braz J Phys Ther, 2015; 19:235–242.
6.
BjornestadA, TysnesOB, LarsenJP, AlvesG: Reliability of three disability scales for detection of independence loss in Parkinson's disease. Parkinsons Dis, 2016; 2016:1941034.
7.
LawtonMP, BrodyEM: Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist, 1969; 9:179–186.
MaoHF, ChangLH, TsaiAY, et al.: Diagnostic accuracy of Instrumental Activities of Daily Living for dementia in community-dwelling older adults. Age Ageing, 2018; 47:551–557.
10.
HoeymansN, WoutersERCM, FeskensEJM, et al.: Reproducibility of performance-based and self-reported measures of functional status. J Gerontol A Biol Sci Med Sci, 1997; 52A:M363–M368.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med, 2002; 166:111–117.
13.
WaatevikM, FriskB, RealFG, et al.: One Year Change in 6-Minute Walk Test Outcomes is Associated with COPD Prognosis. COPD, 2020; 17:662–671.
14.
SalbachNM, MayoNE, HigginsJ, et al.: Responsiveness and predictability of gait speed and other disability measures in acute stroke. Arch Phys Med Rehabil, 2001; 82:1204–1212.
15.
DaullxhiuI, HalitiE, PonikuA, et al.: Predictors of exercise capacity in patients with chronic heart failure. J Cardiovasc Med (Hagerstown), 2011; 12:223–225.
ChowR, BrueraE, TemelJS, et al.: Inter-rater reliability in performance status assessment among healthcare professionals: An updated systematic review and meta-analysis. Support Care Cancer, 2020; 28:2071–2078.
18.
SchagCC, HeinrichRL, GanzPA: Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncol, 1984; 2:187–193.
19.
MillerRJ: Predicting survival in the advanced cancer patient. Henry Ford Hosp Med, 1991; 39:81–84.
OkenMM, CreechRH, TormeyDC, et al.: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol, 1982; 5:649–655.
22.
TaylorAE, OlverIN, SivanthanT, et al.: Observer error in grading performance status in cancer patients. Support Care Cancer, 1999; 7:332–335.
23.
BergerotCD, PhilipEJ, BergerotPG, et al.: Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status. Cancer, 2021; 127:354–358.
24.
Ayala AlvarezJC, Trejo RosalesRR, Riera SalasR, et al.: Functional status as a determinant prognostic factor for overall survival in adult patients with medulloblastoma treated with chemotherapy and radiotherapy. Ann Oncol, 2019:30(Suppl. 9):ix21.
25.
TakahashiM, TakahashiM, KomineK, et al.: The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study. PLoS One, 2017; 12:e0179694.
26.
ChenWJ, KongDM, LiL: Prognostic value of ECOG performance status and Gleason score in the survival of castration-resistant prostate cancer: A systematic review. Asian J Androl, 2021; 23:163–169.
27.
ArgirisA, LiY, ForastiereA: Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck. Cancer, 2004; 101:2222–2229.
28.
XuY, ZhangY, WangX, et al.: Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: A systematic review and meta-analysis. BMC Cancer, 2019; 19:168.
29.
OwusuC, KoroukianSM, SchluchterM, et al.: Screening older cancer patients for a Comprehensive Geriatric Assessment: A comparison of three instruments. J Geriatr Oncol, 2011; 2:121–129.
30.
LauF, DowningGM, et al.: Use of Palliative Performance Scale in end-of-life prognostication. J Palliat Med, 2006; 9:1066–1075.
31.
KaasaT, WesselJ: The Edmonton Functional Assessment Tool: Further development and validation for use in palliative care. J Palliat Care, 2001; 17:5–11.
32.
KaasaT, WesselJ, DarrahJ, BrueraE: Inter-rater reliability of formally trained and self-trained raters using the Edmonton functional assessment tool. Palliat Med, 2000; 14:509–517.